ODDO BHF Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

ODDO BHF Asset Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-25,554	Closed	-$1.15M	–	294
2025 Q3	$1.15M	Sell	25,554 -3,986	-13%	-$186K	0.04%	257
2025 Q2	$1.37M	Sell	29,540 -2,085	-7%	-$102K	0.05%	253
2025 Q1	$1.93M	Buy	+31,625	New	+$1.84M	0.08%	233

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

ODDO BHF Asset Management's BMY Position: Q4 2025 in Review

ODDO BHF Asset Management sold out of Bristol-Myers Squibb (BMY) in Q4 2025, closing a stake of 25,554 shares — an estimated $1.15M sold.

ODDO BHF Asset Management first reported a position in BMY in Q1 2025 and held it in 3 quarters. The position peaked at $1.93M in Q1 2025. 2,447 funds tracked by Wall St. Rank hold BMY as of Q4 2025.

ODDO BHF Asset Management reported no remaining Bristol-Myers Squibb position as of Q4 2025 after selling out during the quarter.
ODDO BHF Asset Management sold 25,554 Bristol-Myers Squibb shares in Q4 2025, an estimated $1.15M.
ODDO BHF Asset Management first reported a position in Bristol-Myers Squibb in Q1 2025 and held it in 3 quarters.
ODDO BHF Asset Management's Bristol-Myers Squibb position peaked at $1.93M in Q1 2025.
2,447 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2025.

Based on ODDO BHF Asset Management's 13F filing for Q4 2025, filed 17 Feb 2026.